VMI
NXTC icon

VHCP Management II’s NextCure NXTC Stock Holding History

VHCP Management II’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$2.04M Buy
+3,021
New +$1.52M 0.54% 16

Other funds holding NXTC

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

VHCP Management II's NXTC Position: Q4 2019 in Review

VHCP Management II opened a new position in NextCure (NXTC) in Q4 2019: 3,021 shares worth $2.04M. The stake represents 0.54% of the portfolio and ranks #16 among its holdings.

88 funds tracked by Wall St. Rank hold NXTC as of Q4 2019.

  • VHCP Management II held 3,021 shares of NextCure worth $2.04M as of Q4 2019.
  • NextCure was a new VHCP Management II position in Q4 2019.
  • NextCure made up 0.54% of VHCP Management II's portfolio in Q4 2019, its #16 holding.
  • 88 funds tracked by Wall St. Rank held NextCure as of Q4 2019.

Based on VHCP Management II's 13F filing for Q4 2019, filed 13 Feb 2020.